As technology evolves, FDA's regulatory frameworks must adapt to avoid needless uncertainty about how reviewers will evaluate novel products or approaches. The post Testimony on Maintaining U.S. Biotech Competitiveness and Delivering Lifesaving Cures to Patients appeared first on USC Schaeffer.
